Biomarin Pharmaceutical BMRN
NASDAQ BMRN
$58.44 -1.56 (-2.60%)
At close: Oct 1, 2026 · 4:00 PM EDT

Biomarin Pharmaceutical (BMRN) Other Non-Current Assets (2009 - 2026)

Updated

Biomarin Pharmaceutical (BMRN) reported Other Non-Current Assets of $338.14 million for Q2 2026, up 35.7% from $249.19 million a year earlier but down 60.2% from the prior quarter.

Analysis

Biomarin Pharmaceutical (BMRN) Other Non-Current Assets (2009 - 2026) Analysis & Trends

At the end of FY2025, Biomarin Pharmaceutical posted Other Non-Current Assets of $277.05 million, up 10.2% from FY2024.

  • Other Non-Current Assets has a five-year compound annual growth rate of 14.3% (FY2020 to FY2025).
  • By year, Other Non-Current Assets came in at $251.39 million in FY2024 (+46.6%), $171.54 million in FY2023 (-2.7%), $176.24 million in FY2022 (+15.9%) and $152.12 million in FY2021 (+6.9%).
  • Five-year quarterly Other Non-Current Assets spans a low of $144.17 million in Q2 2023 and a high of $850 million in Q1 2026.
  • Year over year, Other Non-Current Assets has now increased in each of the last ten quarters, with growth averaging 58.5% over the last eight quarters.
  • The high point for year-over-year Other Non-Current Assets in five years was Q1 2026 (growth of 260.7%); the low point was Q2 2023 (a decline of 5.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $850 million (Q1 2026), $277.05 million (Q4 2025) and $270.78 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Biomarin Pharmaceutical 11.61 Bn 5.48 Bn 786.91 Mn 338.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 338.14 Mn
Mar 31, 2026 850.00 Mn
Dec 31, 2025 277.05 Mn
Sep 30, 2025 270.78 Mn
Jun 30, 2025 249.19 Mn
Mar 31, 2025 235.65 Mn
Dec 31, 2024 251.39 Mn
Sep 30, 2024 199.31 Mn
Jun 30, 2024 190.77 Mn
Mar 31, 2024 184.79 Mn
Dec 31, 2023 171.54 Mn
Sep 30, 2023 165.07 Mn
Jun 30, 2023 144.17 Mn
Mar 31, 2023 150.06 Mn
Dec 31, 2022 176.24 Mn
Sep 30, 2022 151.79 Mn
Jun 30, 2022 151.80 Mn
Mar 31, 2022 149.19 Mn
Dec 31, 2021 152.12 Mn
Sep 30, 2021 144.71 Mn
API Access

Biomarin Pharmaceutical Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=BMRN&period=max&api_key=YOUR_API_KEY